56 related articles for article (PubMed ID: 38715380)
1. NGEF is a potential prognostic biomarker and could serve as an indicator for immunotherapy and chemotherapy in lung adenocarcinoma.
Chen X; Zhang T; He YQ; Miao TW; Yin J; Ding Q; Yang M; Chen FY; Zeng HP; Liu J; Zhu Q
BMC Pulm Med; 2024 May; 24(1):248. PubMed ID: 38764064
[TBL] [Abstract][Full Text] [Related]
2. Down-regulation of KLRB1 is associated with increased cell growth, metastasis, poor prognosis, as well as a dysfunctional immune microenvironment in LUAD.
Chen JL; Wu CY; Luo XY; Wang XY; Wang FM; Huang X; Yuan W; Guo Q
Sci Rep; 2024 May; 14(1):11782. PubMed ID: 38782996
[TBL] [Abstract][Full Text] [Related]
3. Identification of PSMD11 as a novel cuproptosis- and immune-related prognostic biomarker promoting lung adenocarcinoma progression.
Huang Q; Tian R; Yu J; Du W
Cancer Med; 2024 Jun; 13(11):e7379. PubMed ID: 38859698
[TBL] [Abstract][Full Text] [Related]
4. IL1R2 is a Novel Prognostic Biomarker for Lung Adenocarcinoma.
Zhang Y; Ma D; Gong Y; Wang F; Wu J; Wu C
Curr Mol Med; 2024; 24(5):620-629. PubMed ID: 37078353
[TBL] [Abstract][Full Text] [Related]
5. CDCA gene family promotes progression and prognosis in lung adenocarcinoma.
Liu X; Zhu X; Zhao Y; Shan Y; Gao Z; Yuan K
Medicine (Baltimore); 2024 Jun; 103(24):e38581. PubMed ID: 38875380
[TBL] [Abstract][Full Text] [Related]
6. The expression characteristic and prognostic role of Siglec-15 in lung adenocarcinoma.
Sun H; Du Q; Xu Y; Rao C; Xu L; Yang J; Mao Y; Wang L
Clin Respir J; 2024 May; 18(5):e13772. PubMed ID: 38725348
[TBL] [Abstract][Full Text] [Related]
7. Death associated protein kinase 1 predicts the prognosis and the immunotherapy response of various cancers.
Yang J; Liu Y; Geng Q; Wang B
Mol Biol Rep; 2024 May; 51(1):670. PubMed ID: 38787485
[TBL] [Abstract][Full Text] [Related]
8. Gene signatures of endoplasmic reticulum stress and mitophagy for prognostic risk prediction in lung adenocarcinoma.
Lin X; Yang M; Huang Y; Huang X; Shi H; Chen B; Kang J; Ke S
IET Syst Biol; 2024 Jun; 18(3):103-117. PubMed ID: 38813617
[TBL] [Abstract][Full Text] [Related]
9. REEP3 is a potential diagnostic and prognostic biomarker correlated with immune infiltration in pancreatic cancer.
Liu GH; Tan XY; Xu ZY; Li JX; Zhong GH; Zhai JW; Li MY
Sci Rep; 2024 Jun; 14(1):13834. PubMed ID: 38879709
[TBL] [Abstract][Full Text] [Related]
10. HMGN1 loss sensitizes lung cancer cells to chemotherapy.
Wu X; Cai G; Feng J; Lin W
Sci Rep; 2024 May; 14(1):10386. PubMed ID: 38710740
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive bioinformatics analysis of NOX4 as a biomarker for pan-cancer prognosis and immune infiltration.
Liu Y; Huang H; Yang X; Huang D; Wang X; Yuan M; Hong L
Aging (Albany NY); 2024 Apr; 16(8):7437-7447. PubMed ID: 38663913
[TBL] [Abstract][Full Text] [Related]
12. The Pan-Cancer Analysis Uncovers the Prognostic and Immunotherapeutic Significance of CD19 as an Immune Marker in Tumor.
Wei L; Meng J; Xiang D; Yang Q; Zhou Y; Xu L; Chen J; Han Y
Int J Gen Med; 2024; 17():2593-2612. PubMed ID: 38855424
[TBL] [Abstract][Full Text] [Related]
13.
Wang C; Wang J; Chen S; Li K; Wan S; Yang L
Curr Cancer Drug Targets; 2024; 24(3):340-353. PubMed ID: 37592784
[TBL] [Abstract][Full Text] [Related]
14. GJB3: a comprehensive biomarker in pan-cancer prognosis and immunotherapy prediction.
Zeng J; Li X; Zhang Y; Zhang B; Wang H; Bao S; Zu L; Zhang H; Cheng Y; Tang Q; Xu X; Xu S; Song Z
Aging (Albany NY); 2024 May; 16(9):7647-7667. PubMed ID: 38728250
[TBL] [Abstract][Full Text] [Related]
15. Eukaryotic Translation Initiation Factor 2 Subunit β as a Prognostic Biomarker Associates With Immune Cell Infiltration in Breast Cancer.
Guo M; Ying Y; Chen Y; Miao X; Cui H; Yu Z; Wang X
J Surg Res; 2024 Mar; 295():753-762. PubMed ID: 38147761
[TBL] [Abstract][Full Text] [Related]
16. The diagnostic potential role of thioredoxin reductase and TXNRD1 in early lung adenocarcinoma: A cohort study.
Jiang G; Wang X; Xu Y; He Z; Lu R; Song C; Jin Y; Li H; Wang S; Zheng M; Mao W
Heliyon; 2024 Jun; 10(11):e31864. PubMed ID: 38882339
[TBL] [Abstract][Full Text] [Related]
17. GTSE1: A potential prognostic and diagnostic biomarker in various tumors including lung adenocarcinoma.
Yan G; Li G; Gao X; Liu J; Li Y; Li J; Zhou H
Clin Respir J; 2024 May; 18(5):e13757. PubMed ID: 38715380
[TBL] [Abstract][Full Text] [Related]
18. Pan-cancer analyses reveal GTSE1 as a biomarker for the immunosuppressive tumor microenvironment.
Tan K; Fang Z; Kong L; Cheng C; Hwang S; Xu M
Medicine (Baltimore); 2023 Aug; 102(34):e34996. PubMed ID: 37653815
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
